Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 48

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 48
---
 of the date of this prospectus, our directors
and officers and Class B shareholders collectively own an aggregate of 95.83% of the total voting power of our outstanding Ordinary Shares.
Mr. Ka Lun To, our Chairman and Chief Executive Officer, through his holding company, has beneficial ownership and control over 4,680,000
Class A Ordinary Shares and 520,000 Class B Ordinary Shares, representing approximately 52% of our total voting power of our outstanding
Ordinary Shares, and Qingtian Holdings Ltd, the other Class B shareholder, holds 2,820,000 Class A Ordinary Shares and 480,000 Class
B Ordinary Shares, representing approximately 41.75% of our total voting power. See “Principal Shareholder” on page 106 of
this prospectus for details. Immediately after the completion of the offering, our directors and officers and Class B shareholders will
collectively control an aggregate of [*] % of the total voting power of our outstanding Ordinary Shares, Mr. To will be beneficially
interested in an aggregate of [*] % of the total voting power of our outstanding Ordinary Shares, immediately after the completion of
this offering, assuming the underwriters do not exercise their over-allotment option, our Class B shareholders, consisting of LTO Holdings
Ltd, wholly owned by Mr. To and Qingtian Holdings Ltd will own an aggregate of [●]% of our total voting power of our outstanding
Ordinary Shares. Assuming the two Class B shareholders continue to hold 7,500,000 Class A Ordinary Shares and 1,000,000 Class B Ordinary
Shares, so long as the total ordinary shares hold by the two Class B shareholders represent more than 26.7% of our total outstanding
ordinary shares, the two Class B shareholders, if vote together, will continue to control the outcome of matters submitted to shareholders
for approval. In cases where their interests are aligned and they vote together, our directors and officers who are beneficial owners
and the Class B Shareholders could have significant influence on determining the outcome of any corporate transaction or other matter
submitted to the shareholders for approval, including mergers, consolidations, the election of directors and other significant corporate
actions. In cases where their interests are aligned and they vote together, they will also have the power to prevent or cause a change
in control. Without the consent of some or all of these shareholders, we may be prevented from entering into transactions that could
be beneficial to us or our